Showing results (1-10 of 1,274) with videos related to

Sort By:
Pageof 128
Human Reproduction (Oxford, England)|May 1, 1993
The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndromeF Scheele, P G Hompes, M van der Meer, et al.
Human Reproduction (Oxford, England)|November 1, 1993
Pulsatile gonadotrophin releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndromeF Scheele, P G Hompes, M van der Meer, et al.
Fertility and Sterility|October 1, 1993
The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatmentF Scheele, P G Hompes, M van der Meer, et al.
Human Reproduction (Oxford, England)|September 1, 1994
Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndromeM van der Meer, P G Hompes, F Scheele, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 1, 1995
Exploring the recovery phase after treatment with a gonadotrophin-releasing hormone-agonist for ovulation induction in polycystic ovary syndrome: three pilot trialsF Scheele, M van der Meer, C B Lambalk, et al.
Fertility and Sterility|October 1, 1996
The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized studyM van der Meer, P G Hompes, F Scheele, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 1, 1996
The role of follicle-stimulating hormone in the selection of follicles in human ovaries: a survey of the literature and a proposed modelF Scheele, J Schoemaker
Human Reproduction (Oxford, England)|June 1, 1993
Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like diseaseM M van Weissenbruch, H C Schoemaker, H A Drexhage, et al.
Human Reproduction (Oxford, England)|July 13, 1999
Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndromeM H van Hooff, M van der Meer, C B Lambalk, et al.
Human Reproduction (Oxford, England)|August 4, 1998
Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndromeM van der Meer, J A de Boer, P G Hompes, et al.
Pageof 128